Resistance to nucleoside reverse transcriptase (RT) inhibitors is conferred on human immunodeficiency virus type 1 through thymidine analogue resistance mutations (TAMs) that increase the ability of RT to excise chain-terminating nucleotides after they have been incorporated. The RT mutation M184V is a potent suppressor of TAMs. In RT containing TAMs, the addition of M184V suppressed the excision of 3=-deoxy-3=-azidothymidine monophosphate (AZTMP) to a greater extent on an RNA template than on a DNA template with the same sequence. The catalytically inactive RNase H mutation E478Q abolished this difference. The reduction in excision activity was similar with either ATP or pyrophosphate as the acceptor substrate. Decreased excision of AZTMP was associated with increased cleavage of the RNA template at position ؊7 relative to the primer terminus, which led to increased primer-template dissociation. Whether M184V was present or not, RT did not initially bind at the ؊7 cleavage site. Cleavage at the initial site was followed by RT dissociation and rebinding at the ؊7 cleavage site, and the dissociation and rebinding were enhanced when the M184V mutation was present. In contrast to the effect of M184V, the K65R mutation suppressed the excision activity of RT to the same extent on either an RNA or a DNA template and did not alter the RNase H cleavage pattern. Based on these results, we propose that enhanced RNase H cleavage near the primer terminus plays a role in M184V suppression of AZT resistance, while K65R suppression occurs through a different mechanism. R everse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1) is the key enzyme responsible for the synthesis of a double-stranded copy of the HIV genome that is subsequently integrated into the host chromosome during HIV infection. Treatment of HIV-1-infected patients with RT inhibitors such as 3=-deoxy-3=-azidothymidine (zidovudine, AZT) leads to selection of mutations in RT known as thymidine analogue resistance mutations (TAMs), which include M41L, D67N, K70R, L210W, T215Y or F, and K219Q or E. RTs containing various combinations of these mutations have an elevated excision activity that allows them to remove AZT monophosphate (AZTMP) and other chain-terminating nucleotides after they have been incorporated (1, 2, 10, 33) . Treatment of HIV-1-infected patients with (Ϫ)2=,3=-dideoxy-3=-thiacytidine (lamivudine, 3TC) or (Ϫ)2=, 3=-dideoxy-5-fluoro-3=-thiacytidine (emtricitabine, FTC) leads to selection of the M184I mutation in RT, which is rapidly replaced with M184V (7, 25, 52, 57) . The M184V mutation is a potent suppressor of AZT resistance conferred by TAMs (7, 30, 40, 57) , and this suppressor activity is thought to contribute to the beneficial effects of therapies that include 3TC or FTC in combination with other nucleoside RT inhibitors (19, 30, 40, 44, 56) .
R
everse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1) is the key enzyme responsible for the synthesis of a double-stranded copy of the HIV genome that is subsequently integrated into the host chromosome during HIV infection. Treatment of HIV-1-infected patients with RT inhibitors such as 3=-deoxy-3=-azidothymidine (zidovudine, AZT) leads to selection of mutations in RT known as thymidine analogue resistance mutations (TAMs), which include M41L, D67N, K70R, L210W, T215Y or F, and K219Q or E. RTs containing various combinations of these mutations have an elevated excision activity that allows them to remove AZT monophosphate (AZTMP) and other chain-terminating nucleotides after they have been incorporated (1, 2, 10, 33) . Treatment of HIV-1-infected patients with (Ϫ)2=,3=-dideoxy-3=-thiacytidine (lamivudine, 3TC) or (Ϫ)2=, 3=-dideoxy-5-fluoro-3=-thiacytidine (emtricitabine, FTC) leads to selection of the M184I mutation in RT, which is rapidly replaced with M184V (7, 25, 52, 57) . The M184V mutation is a potent suppressor of AZT resistance conferred by TAMs (7, 30, 40, 57) , and this suppressor activity is thought to contribute to the beneficial effects of therapies that include 3TC or FTC in combination with other nucleoside RT inhibitors (19, 30, 40, 44, 56) .
Methionine 184 is part of the YMDD signature motif that makes up the polymerase active site of HIV-1 RT and lies near the binding sites for the primer terminus and the incoming deoxynucleoside triphosphate (dNTP) (28, 31) . M184I is usually selected first during therapy with 3TC or FTC, and structural studies to investigate the molecular mechanism of drug resistance have focused on RT containing this mutation. A cocrystal structure of M184I mutant RT with a DNA-DNA primer-template (P/T) shows changes in the positioning of the primer terminus and the dNTP binding site due to the mutation, leading to a model that explains 3TC and FTC resistance through an increased ability of the mutant enzyme to exclude the analogs in favor of the natural substrate, dCTP (50) . M184I RT is defective in binding to natural dNTPs and has defects in primer extension and processivity, as well as increased strand-switching activity (26, 29) . These defects result in impaired fitness in vivo, and the M184I mutation is rapidly replaced with M184V during prolonged therapy (52, 53) . M184V RT also has a mild defect in processivity (3-5, 8, 23, 39, 54) and ternary complex (RT-dNTP-P/T) stability (18, 24) accompanied by modest reductions in affinity for natural dNTPs (15, 20, 60) , but this mutant is selected because of a fitness advantage in vivo. Selection experiments in a TAM background resulted in M184V with no evidence of an M184I intermediate (30) , and M184V is usually the only mutation detected at RT position 184 in HIV-1-infected patients undergoing prolonged 3TC therapy (53) . The present study focused on M184V since it is the mutation most relevant to ongoing clinical suppression of AZT resistance.
The biochemical basis of M184V suppression of TAMs has been the subject of several studies (9, 21, 22, 27, 32, 38, 39, 49, 58, 62) . Typically, the M184V mutation confers a reduction in excision activity that can be observed on either RNA or DNA templates. Here we compared M184V-dependent reductions in excision activity on both RNA and DNA templates with the same sequence. Suppression of excision was consistently greater on an RNA template than on a DNA template. This increased suppression depended on the RNase H activity of RT and was associated with enhanced RNase H cleavage at sites in the template near the primer terminus that result in dissociation of the P/T duplex. The M184V mutation favored dissociation of the mutant RT from the site of initial cleavage, resulting in enhanced binding and cleavage at a downstream site near the primer terminus, leading to the dissociation of P/T, which disfavors excision.
MATERIALS AND METHODS
Expression and purification of wild-type (WT) RT (RT WT ) and mutant HIV-1 RTs. His-tagged HIV-1 RT was prepared as previously described, using expression vector pKRT2, which contains RT coding sequence from the HIV-1 BH10 background (12) , or pTRc99 (Pharmacia Biotech), which contains RT coding sequence from the HIV-1 LAI background (55) . pKRT2 was obtained from the AIDS Research and Reference Reagent Program (contributed by Richard D'Aquila and William C. Summers). Proviral clones of HIV-1 WT-LAI and RT mutants in the LAI background containing restriction sites XbaI and XmaI bracketing most of the RT coding sequence were provided by John Mellors. The XbaIXmaI fragment was transferred into a pTRc99 expression vector, also provided by John Mellors. The expression vectors were further modified by adding an N-terminal polyhistidine tail as previously described (34, 35 (51) or by site-directed mutagenesis using the QuikChange II kit (Agilent Technologies) and confirmed by sequencing. WT and mutant RTs were purified as previously described (34) and were predominantly homodimeric. For all assays, RT was added in 20-to 40-fold excess over the P/T concentration based on the RT protein concentration with no adjustment made for differences in specific activity.
Labeled and unlabeled oligonucleotides. Oligodeoxynucleotides L33 (5=-CTACTAGTTTTCTCCATCTAGACGATACCAGAA-3=), D19 (5=-C TACTAGTTTTCTCCATC-3=), and D50 (5=-GAGTGCTGAGGTCTTCA TTCTGGTATCGTCTAGATGGAGAAAACTAGTAG-3=) were purchased from Sigma Genosys and gel purified prior to use. Where indicated, L33 was 5= labeled with [␥-32 P]ATP (Perkin-Elmer Life Sciences) and T4 polynucleotide kinase (Promega Corp.). Labeled DNA was separated from unincorporated nucleotide using Micro Bio-Spin Columns (P-30 columns, RNase-Free; Bio-Rad Laboratories), followed by phenol-chloroform extraction and ethanol precipitation. The 5=-biotinylated L33 oligodeoxynucleotide was purchased from Eurofins MWG Operon and gel purified before use. RNA template R52 (5=-GGGAGUG CUGAGGUCUUCAUUCUGGUAUCGUCUAGAUGGAGAAAACUAG UAG-3=) was synthesized by in vitro transcription by following the manufacturer's protocol (T7-MEGA-shortscript kit; Ambion, Inc.). In brief, 500 nM DNA duplex formed by the oligonucleotide 5=-AATTTAATACG ACTCACTATAGGGAGTGCTGAGGTCTTCATTCTGGTATCGTCTAG ATGGAGAAAACTAGTAG-3= annealed to its complement was incubated for 4 h with T7 RNA polymerase and NTPs at 37°C, treated with RNasefree DNase I (Ambion, Inc.) for 20 min at 37°C, and then heated at 95°C for 5 min. Unincorporated nucleotides were removed with P-30 columns, followed by treatment with 1 U shrimp alkaline phosphatase (Promega Corp.) in the presence of RNase inhibitor (20 U of RNasin-Plus; Promega Corp.) for 30 min at 37°C. The phosphatase was inactivated by heating for 5 min at 95°C, and the unlabeled RNA was gel purified, phenol-chloroform extracted, and ethanol precipitated. Alternatively, after gel purification, the RNA was 5= labeled with [␥-32 P]ATP and T4 polynucleotide kinase in a reaction mixture containing 20 U of RNasin-Plus, and labeled nucleotide was removed by centrifugation through a P-30 column, followed by phenol-chloroform extraction and ethanol precipitation.
Excision rescue of AZTMP-terminated P/Ts. Sixteen picomoles of 5=-32 P-labeled L33 was annealed with 32 pmol of unlabeled R52 or D50
and incubated with 10 M AZTTP and 190 nM RT M41L/T215Y/E478Q in RB-10 buffer (final concentrations, 10 mM MgCl 2 , 40 mM HEPES [pH, 7.5], 60 mM KCl, 1 mM dithiothreitol, 2.5% glycerol, and 80 g/ml bovine serum albumin) and 20 U of RNasin-Plus in a total volume of 300 l for 1 h at 37°C. The 32 P-labeled, chain-terminated P/T was purified by centrifugation through a P-30 column, phenolchloroform extraction, and ethanol precipitation and resuspended in buffer containing 10 mM Na-HEPES (pH 7.4) and 60 mM KCl. Chain termination was 90 to 94% complete based on primer extension experiments. Excision rescue experiments were initiated by adding WT or mutant RT (110 to 250 nM) to a mixture containing 5 nM 5=-32 P-L33-AZT primer annealed to unlabeled R52 or D50 template in RB-10 buffer with the four dNTPs at 10 M (each) and 3.2 mM ATP or 15 or 50 M pyrophosphate (PP i ) in a final volume of 10 l. The ATP and dNTPs were purchased from GE Healthcare and treated with thermostable pyrophosphatase (Roche Applied Science) as previously described (37) . The reaction mixtures were incubated at 37°C for various times (1 to 30 min) and terminated by heating at 90°C for 4 min. An equal volume of 2ϫ urea-TTE loading buffer (16 M urea, 180 mM Tris, 58 mM taurine, 1 mM EDTA, 0.5% bromphenol blue, 0.5% xylene cyanol) was added, and the primer extension products were separated from unextended primer by electrophoresis on 10% polyacrylamide denaturing gels containing 8 M urea. The amount of radioactivity in extended primer was determined on a dried gel with a PhosphorImager (Molecular Dynamics Storm 840) and expressed as a percentage of the total labeled primer detected in the gel. Results are presented without correction for primer extension that occurred in the absence of added ATP or PP i (6 to 10%). Results of repeated experiments were averaged after normalization to the percent extended primer formed in the same experiment by RT WT after 15 min of incubation. Detection and quantification of RNase H cleavage products. 5=-32 Plabeled R52 template (12 pmol) was annealed with 24 pmol of unlabeled L33 or D19 primer and incubated with 10 M AZTTP, 125 nM RT M41L/T215Y/E478Q , and 20 U of RNasin-Plus in RB-10 buffer in a total volume of 150 l for 1 h at 37°C. Unincorporated AZTTP was removed by passage through a P-30 spin column. AZTMP-terminated P/T was isolated by phenol-chloroform extraction and ethanol precipitation and resuspended in buffer containing 10 mM Na-HEPES (pH 7.4) and 60 mM KCl. Aliquots of labeled template-primer were incubated with WT or mutant RTs in RB-10 buffer containing 20 U of RNasin-Plus (final volume, 10 l) for various times (5 to 30 min), and the reactions were terminated by heating for 4 min at 90°C and the addition of an equal volume of 2ϫ urea-TTE loading buffer. The RNase H cleavage products were fractionated by electrophoresis on 10% polyacrylamide denaturing gels, and degradation products were quantified by PhosphorImager and expressed as a percentage of the total RNA template.
Detection of primer-bound and released RNase H cleavage fragments. 5=-32 P-labeled R52 template (12 pmol) was annealed with 24 pmol of unlabeled 5=-biotinylated L33 oligonucleotide and terminated with AZTMP as described above. After purification by P-30 spin columns, phenol-chloroform extraction, and ethanol precipitation, the AZT-terminated, biotinylated P/T was resuspended at a concentration of 100 nM and incubated with streptavidin (SA)-conjugated magnetic beads (Dynabeads M-280 SA; Invitrogen) (30 g of SA-beads, 0.1 pmol of biotinylated primer) for 30 min at room temperature. The indicated mutant RT (110 to 250 nM) was added, and the suspension was incubated as described for RNase H cleavage assays. At the time points indicated, free and SA-bound fractions were separated using a magnet. Samples were diluted with an equal volume of 2ϫ urea-TTE loading buffer and heated for 4 min at 90°C, and free and SA-bound RNase H cleavage products were fractionated by gel electrophoresis and detected as described above.
RESULTS
Effect of the M184V mutation on ATP-mediated excision of AZTMP from a chain-terminated primer. Excision rescue of a 5=-32 P-labeled AZTMP-terminated DNA primer was evaluated by primer extension assays carried out in the presence of WT or mutant RT, ATP as the excision acceptor substrate, and all four dNTPs. Transfer of the chain-terminating AZTMP to ATP by the excision activity of RT produces an unblocked primer that is extended by the DNA-polymerizing activity of RT. Figure 1 shows the rescue of AZTMP-terminated primer by WT and mutant RTs carried out with DNA template (Fig. 1A , B, E, and F) or with RNA template (Fig. 1C, D , E, and G). As previously reported (35) , excision activity was substantially increased in RT containing the M41L and T215Y mutations (RT M41L/T215Y ) in comparison with RT WT . The increases were similar for RNA and DNA templates. Addition of the M184V mutation to an M41L/T215Y background (RT M41L/M184V/T215Y ) had a variable effect on excision when tested on a DNA template (Fig. 1A and B) . In some experiments, the M184V mutation suppressed primer rescue by as much as 25%, and in other experiments, the reduction was less than 10% (the error bars reflect this variability). On an RNA template, the addition of M184V to an M41L/T215Y background consistently reduced primer rescue by 50 to 60% (Fig. 1C and D) .
To determine whether the RNase H activity of RT was responsible for the difference seen with RNA or DNA templates, the E478Q mutation was introduced into these enzymes (RT M41L/T215Y/E478Q and RT M41L/M184V/T215Y/E478Q ). The E478Q mutation knocks out RNase H catalytic activity in HIV-1 RT. When E478Q was present, the M184V mutation failed to significantly reduce excision rescue on either a DNA or an RNA template (Fig. 1E, F, and G) . For a quantitative summary of multiple experiments, see Fig. 6A . These results suggest that a major portion of the effect of M184V on excision is dependent on the RNase H activity of RT.
Dependence of AZTMP excision on RT concentration. Rates of excision with different concentrations of the mutant RTs were compared (Fig. 2) . With all four mutant RTs, the excision reaction approached saturation at 200 nM RT. On an RNA template, excision rescue was reduced 60 to 70% when M184V was present, with little dependence on the RT concentration ( Fig. 2A and C) . On a DNA template, excision rescue was reduced 25 to 30% when M184V was present over the same range of RT concentrations (Fig. 2B) . In contrast, when E478Q was present, M184V enhanced the rate of excision on both RNA and DNA templates at low RT concentrations. At higher RT concentrations, M184V stimulated excision on a DNA template but not on an RNA template ( Fig. 2D and E). Since our assays measure excision as a single-turnover reaction, which is approximately linear for 15 min, the initial rates of excision were estimated from the percentage of primer rescue observed after 15 min of incubation. The excision rate data as a function of the RT concentration were fitted to a hyperbolic equation to determine the apparent K D and maximum rate of excision (k excis ) at saturating RT and physiological ATP concentrations (Table 1) . Addition of M184V to RT M41L/T215Y increased the apparent K D from 23 to 93 nM on an RNA template. The effect was much smaller on a DNA template (21 nM without M184V compared with 29 nM when the M184V mutation was present). A reduction of k excis was observed on both DNA and RNA templates when M184V was present. When M184V was added to RT lacking RNase H activity (RT M41L/T215Y/E478Q ), the K D was decreased to a similar extent on either an RNA or a DNA template and there was no significant effect of M184V on k excis on either template.
RNase H cleavage and P/T dissociation after cleavage. RNA template (R52) was labeled with 32 P and annealed to primer L33-AZT or D19-AZT (shown at the top of Fig. 3A) , and RNase H cleavage products were monitored by gel electrophoresis (Fig.  3A) . We observed major cleavage sites at Ϫ12 and Ϫ7 for P/T L33-AZT/R52 and at Ϫ18 and Ϫ8 for P/T D19-AZT/R52. Nucleotide numbering is given relative to the primer terminus, which is designated Ϫ1. In both sequence contexts, RT that contained the M184V mutation showed enhanced secondary-site cleavage. The product of cleavage at Ϫ7 predominated after 5 min of incubation. For quantification of the Ϫ7 cleavage products formed after 15 min of incubation with the L33-AZT primer and the R52 template, see Fig. 6B .
To determine whether the RNase H cleavages observed in these experiments resulted in P/T dissociation, a biotin-labeled, AZTterminated primer (biotin-L33) was annealed to 5=-32 P-labeled R52 template (shown at the top of Fig. 3B ), and SA-conjugated magnetic beads were used to separate RNase H cleavage products that remained associated with the primer from those that were released during incubation (Fig. 3B) . The results show that Ϫ12 cleavage products remained associated with the primer but Ϫ7 cleavage products were quantitatively released. DNA-RNA duplexes with less than 10 bp have a reduced ability to support either polymerization or ATP-dependent excision, presumably due to the instability of the duplex structure (16, 46) . Addition of M184V to the RT M41L/T215Y background enhanced the release of Ϫ7 cleavage products, indicating that the remaining DNA-RNA P/T duplex was unstable. Similar effects of the M184V mutation were observed for ddAMP-terminated primer annealed to R52 template and for ddAMP-terminated P/T with an unrelated sequence (data not shown). These results suggest that cleavages within 7 bp of the primer terminus are enhanced when the M184V mutation is present, giving rise to increased P/T dissociation.
RNase H cleavage patterns in the presence of a trap. To evaluate the role of the initial RT binding sites in determining the RNase H cleavage events, mutant RTs with or without the M184V mutation were preincubated with a 5=-labeled RNA template annealed to an unlabeled, AZTMP-terminated DNA primer in the absence of MgCl 2 . After 5 min of preincubation, 15 mM MgCl 2 and an excess of poly(rA)-oligo(dT) were added to the mixture and the incubation was continued. Samples were taken after various times of additional incubation, and RNase H cleavage products were fractionated by electrophoresis (Fig. 4A) . For both RT M41L/T215Y and RT M41L/M184V/T215Y , the predominant cleavage products corresponded to RNase H cleavage at positions Ϫ17 and Ϫ12, but cleavage at Ϫ7 was not observed, even after 30 min of incubation. Cleavage at Ϫ17 occurred more rapidly than that at Ϫ12. After 30 min, 70 to 90% of the uncleaved template was depleted, indicating that most of the P/T was saturated with RT during the preincubation and that binding of RT usually led to cleavage prior to dissociation.
These results indicate that RT binds predominantly at two alternative positions on this P/T. Binding in the upstream position placed the RNase H active-site residues at the primary RNA cleavage site (leading to Ϫ17 cleavage). Binding at the downstream position placed the RNase H active-site residues at a secondary cleavage site (leading to Ϫ12 cleavage). RT M41L/T215Y favored Ϫ17 cleavage, whereas RT M41L/M184V/T215Y slightly favored the Ϫ12 cleavage site. Figure 4B indicates that about 23% of the initial binding by RT M41L/T215Y occurs at the Ϫ12 cleavage site, whereas greater than 40% of the initial binding by RT M41L/M184V/T215Y occurs at this site. Neither enzyme was initially bound in a position that allowed cleavage at Ϫ7 to occur, despite the fact that incubation in the absence of a trap resulted in most of the template being cleaved at Ϫ7 after 30 min. This agrees with results previously reported by Brehm et al. (11) and suggests that RT dissociates after cleavage at the initial binding site and rebinds at the downstream site on the P/T, leading to cleavage near the primer terminus and P/T dissociation.
FIG 2
Effect of RT concentration on rescue of AZTMP-terminated primer annealed to RNA or DNA template. Experiments were carried out as described in the legend to Fig. 1 , except that the RT concentrations were 5, 25, 50, 100, and 200 nM and incubation was for 15 min. (A) Representative autoradiogram of rescue of AZTMP-terminated primer annealed to RNA template by mutant RTs as indicated. Reaction mixtures were fractionated by electrophoresis on 10% denaturing polyacrylamide gels. The positions of the unextended primer (Primer) and primer extension products (Extended primer) are indicated to the right. Excess DNA template (B and D) or RNA template (C and E) was annealed to 5=-32 P-labeled L33 and terminated with AZTMP. P/T at 5 nM was incubated with different RTs as indicated for 15 min in the presence of 3.2 mM ATP and 10 M dNTPs. The percentage of the primer that was extended (percent rescue) was determined using a PhosphorImager. Values are the mean of two or more experiments Ϯ the standard deviation. Where error bars are not visible, they are hidden by the data symbols. The apparent K D for the RT-P/T interaction and the apparent k excis for the maximum rate of excision at a saturating RT concentration and a physiological ATP concentration are given in Table 1 .
Additional experiments were carried out to evaluate the effect of M184V on the dissociation of RT from the initial binding sites (Fig. 4C) . RT M41L/T215Y and RT M41L/M184V/T215Y were preincubated with labeled, AZT-terminated P/T in the absence of MgCl 2 , and various concentrations of unlabeled, AZT-terminated P/T (trap) were added to the reaction mixture together with 15 mM MgCl 2 to initiate RNase H activity. Unlabeled P/T competed with labeled P/T for binding of RT after its dissociation from the initial binding site, leading to reduced Ϫ7 cleavage and protection of the Ϫ17 product from secondary-site cleavage. When the M184V mutation was present, higher concentrations of the trap were required to inhibit Ϫ7 cleavage and stabilize the Ϫ17 cleavage product, suggesting that dissociation of the initially bound RT from the labeled P/T was enhanced by the M184V mutation.
Effect of the M184V mutation on ATP-mediated excision rescue and RNase H cleavage in a D67N/K70R/T215F/K219Q background. RT D67N/K70R/T215F/K219Q supports a high level of excision. The addition of M184V to these mutations reduced primer rescue by 30 to 60% when tested on an RNA template (Fig. 5B ) but did not reach the level of significance when tested on a DNA template (Fig. 5A) . Quantitative comparisons after 15 min of incubation are shown in Fig. 6A (expressed as the amount of extended primer relative to RT WT ). A similar effect of M184V was observed in either the RT M41L/T215Y or the RT D67N/K70R/T215F/K219Q background. Figure 5C shows the formation of Ϫ7 cleavage products on L33-AZTMP/R52 P/T as a function of time of incubation, and a quantitative comparison after 15 min of incubation is summarized in Fig.  6B . The addition of M184V to the RT D67N/K70R/T215F/K219Q background resulted in an about 2-fold increase in the formation of the Ϫ7 cleavage product, which is less than the 5-fold increase seen after the addition of M184V to the RT M41L/T215Y background. Both results are consistent with a major role for increased cleavage at Ϫ7 in the RNA template in M184V suppression of AZT resistance.
Effect of M184V on excision mediated by PP i . The results presented above suggest an indirect mechanism for M184V suppression of TAMs leading to the prediction that the reduced primer rescue may be independent of excision acceptor substrate. Figure  7 shows that the addition of M184V to an RT D67N/K70R/T215F/K219Q background reduced excision rescue mediated by 15 M PP i by 36 to 43% on an RNA template ( Fig. 7B) and had little effect when a DNA template was used (Fig. 7A) . The rate of excision was greater when 50 M PP i was provided as the acceptor substrate, but the effect of M184V was similar (51 to 54% reduced rescue after 5 to 10 min) (Fig. 7C) . The effect of M184V on primer rescue was quantitatively similar with ATP as the acceptor substrate in this TAM background (46% reduction, Fig. 6A ). PP i - ) were determined by fitting the observed percent rescue plots (Fig. 2) to the following equation:
. The values shown are means Ϯ standard deviations of two or three experiments.
FIG 3
Effect of the M184V mutation in the M41L/T215Y background on the formation and release of RNase H cleavage products. (A) Excess unlabeled L33 or D19 was annealed to 5=-32 P-labeled R52, terminated with AZTMP, and incubated with the indicated mutant RTs for 5, 10, 15 or 30 min. Major RNase H cleavage positions (measured from the primer terminal AZT) are shown at the top and on the left (for L33-AZT P/T) and right (for D19-AZT P/T) of the gel. (B) Biotinylated L33 was annealed to 5=-32 Plabeled R52, terminated with AZTMP, and incubated with the indicated mutant RTs in the presence of SA-tagged magnetic beads. At 5, 10, 15, or 30 min, SA-bound and unbound (free) fractions were separated with a magnet. Samples were fractionated by electrophoresis on 10% denaturing polyacrylamide gels. mediated excision was also reduced by the addition of M184V to an RT M41L/T215Y background (data not shown). No reduction was seen when the E478Q RNase H-negative mutation was also present. P-labeled R52 template annealed to unlabeled L33 primer, terminated with AZTMP, and preincubated as described above. Unlabeled L33-AZTMP/R52 P/T trap (1, 5, 50, 100, 200, and 600 nM) was added together with15 mM MgCl 2 . After 15 min of further incubation, the reaction products were fractionated by electrophoresis as described above. Controls without L33-AZTMP/R52 ((Ϫ) Trap) are indicated.
FIG 5
Effect of the M184V mutation in a D67N/K70R/T215F/K219Q background on rescue of AZTMP-terminated primer and formation of Ϫ7 RNase H cleavage product. (A) DNA (D50) or (B) RNA (R52) template was annealed to 5=-32 P-labeled L33 primer, terminated with AZTMP, and incubated with mutant RTs as indicated. The extended product is expressed as a ratio of the extended products formed in 15 min by RT WT-BH10 as described in the legend to Fig. 1 . (C) Unlabeled L33 primer was annealed with 5=-32 P-labeled R52, terminated with AZTMP, and incubated with mutant RTs. Products of template cleavage at position Ϫ7 were detected as described in the legend to Fig. 3 and expressed as a percentage of the total radioactivity in the lane.
Effect of K65R on excision rescue and formation of RNase H cleavage products. K65R is also a suppressor of AZT resistance by TAMs (6, 36, 43, 59) , and AZTMP excision activity is reduced in RTs containing this mutation (21, 36, 59 ). In contrast to the results obtained with M184V, the addition of K65R to the RT D67N/K70R/T215Y/K219Q background reduced AZTMP excision activity to similar extents on both DNA (Fig. 8A ) and RNA templates (Fig. 8B) . Quantitative comparison of excision after incubation for 15 min is summarized in Fig. 8D . The RNase H cleavage pattern was not significantly different for RT D67N/K70R/T215Y/K219Q with or without K65R (Fig. 8C) . These results suggest that the mechanisms of suppression of excision rescue are different for K65R and M184V. 
DISCUSSION
Enhanced AZTMP excision by RTs containing two to four TAMs was suppressed by the M184V mutation as previously reported. We show that M184V suppression was greater when DNA synthesis occurred on an RNA template than when it occurred on a DNA template. The excision activity was reduced to a similar extent when measured with either ATP or PP i as the acceptor substrate. While total RNase H activity, as measured by disappearance of the full-length template, was not significantly altered by the M184V mutation (in agreement with reference 62, we show that in the presence of TAMs, M184V selectively enhanced cleavage at a downstream RNase H cleavage site near the primer terminus (position Ϫ7 on the template). This cleavage leads to P/T dissociation. Trap experiments that detect only cleavage at the initial binding sites indicated that RT first bound and cleaved at Ϫ17 or Ϫ12 and then dissociated and rebound at the downstream site to produce Ϫ7 cleavage products. Our results suggest that the M184V mutation enhances dissociation from the initial binding sites, resulting in increased downstream binding.
Previous studies have shown that M184V added to a TAM background reduced excision on RNA templates (32, 48, 58, 62) and DNA templates (9, 21, 22, 27, 38, 49, 62 ) by 16 to 58%, though no decrease was detected in one study (39) . We found the effect on a DNA template to be variable, ranging from no effect to a 34% decrease. We observed a consistently greater reduction in excision with an RNA template than with a DNA template with the same sequence. This difference was dependent on the RNase H activity of RT. Enhanced cleavage at position Ϫ7 on the template due to the presence of the M184V mutation leads to P/T dissociation and would account for reduced excision.
Delviks-Frankenberry et al. (13) have shown that several connection domain mutations, including G335C/D, N348I, A360I/N, V365I, and A376S, obtained from treatment-experienced HIV-1-infected patients increased AZT resistance in the context of TAMs. These connection domain mutations also produced significantly lower RNase H activity and greater AZTMP excision on an RNA template than on a DNA template. These authors proposed that a balance exists between the RNase H and excision activities of HIV-1 RT that is disrupted by these mutations (13, 14, 41, 42) . Reduced RNase H cleavage indirectly enhances AZTMP excision by increasing the time during which excision can occur before RNase H cleavage reduces the length of the P/T duplex to the point where it dissociates. The stimulation of excision activity was observed for either ATP or PP i as the acceptor substrate (13, 16, 58) , which is consistent with the indirect mechanism proposed. Considerable experimental support for this mechanism has been reported (11, 13, 16, 17, 42, (46) (47) (48) 61) . The model also predicts that mutations that enhance RNA cleavage will decrease excision activity. This prediction is supported by our results showing that enhanced Ϫ7 cleavage by RT due to M184V is correlated with decreased excision activity. One additional prediction of the model is that connection domain mutations such as N348I, which reduce secondary-site RNase H cleavage, may compensate for the reduced excision caused by M184V. Compensation was not observed in two studies (41, 61) , but partial compensation was observed in two other studies (48, 58) . We show that M184V strongly enhances Ϫ7 cleavage when present in a background of TAMs; however, the effect is much less in the absence of TAMs, as has also been reported by other laboratories (24, 26, 58, 62) .
The binding affinity of RT for P/T is driven primarily by residues near the primer terminus causing RT to bind preferentially in the polymerase mode (16) . RTs containing the M184V or M184I mutation are known to have reduced processivity for DNA synthesis (3-5, 8, 23, 54) , and the RT-dNTP-P/T ternary complexes formed by these mutant RTs have decreased stability (18, 24; Acosta-Hoyos, unpublished data), suggesting that RTs containing M184V or M184I are bound more weakly and dissociate more readily from the P/T. Increased dissociation of the mutant RT from its initial binding sites would increase the likelihood of rebinding at secondary cleavage sites, thereby increasing the rate of cleavage at these sites. We show that initial binding of TAM-containing RTs with or without M184V occurs at the primer terminus, leading to Ϫ17 cleavage, and at a secondary site five nucleotides downstream, leading to Ϫ12 cleavage. Initial binding is shifted to favor the Ϫ12 cleavage position by addition of M184V, which is consistent with reduced affinity at the primer terminus due to this mutation. Our results (Fig. 4A) and those of Brehm et al. (11) show that cleavage within 10 nt of the primer terminus occurs only after RT has first bound and cleaved at an initial upstream binding site. The mechanism of this sequential pattern of cleavage is not clear, but it may help RT avoid cleavage events that would lead to P/T dissociation during ongoing DNA synthesis (45) . A model of reduced excision due to the M184V mutation is shown in Fig. 9 .
Other mutations in HIV-1 RT are known to reduce excision activity and suppress the AZT-resistant phenotype of TAMs (reviewed in reference 1). One of these is K65R, which affects interactions with the phosphate chain of the incoming dNTP. In this report, we show that addition of K65R to a TAM background reduced excision activity to similar extents on DNA and RNA templates. We found no evidence of an RNase H-dependent component for K65R suppression and conclude that the mechanism of suppression by this mutation is distinct from that of M184V. Other known TAM suppressors include the L74V and Y181C mutations. Radzio et al. (48) have shown an increase in Ϫ10 site RNase H cleavage when Y181C is added to an N348I background. Parallel experiments did not show a similar effect of L74V on Ϫ10 cleavage.
The ability of the M184V mutation to increase the sensitivity of HIV-1 to nucleoside RT inhibitors has played an important role in antiretroviral therapy for at least 15 years due to the extensive therapeutic use of 3TC or FTC together with thymidine analogue nucleoside RT inhibitors. Our studies contribute to the understanding of the biochemical mechanisms that underlie the ability of this mutation to suppress resistance to AZT and other nucleosides. These insights may lead to the improvement of familiar antiviral therapies and the development of new therapeutic strategies.
